Product Information

MECLIZINE 12.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0462 per EA under NDC 59651080701. Its NADAC has been published 116 times since Jun 5, 2024.

FDA first approved this application on Sep 17, 2012. Its Orange Book therapeutic-equivalence code is AA.

MECLIZINE 12.5 MG TABLET

MECLIZINE
$0.0462per EA

Strength

12.5 mg/1

NDC

59651080701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MECLIZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202640

FDA Approved

9/17/2012

TE Code

AA

On Market Since

9/14/2023

Pharmacological Classes

Antiemetic
Emesis Suppression

Price Statistics

The NADAC for MECLIZINE 12.5 MG TABLET has been published 116 times since Jun 5, 2024, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0462 per EA
All-time high$0.0638 (Jul 10, 2024)
All-time low$0.0418 (Nov 20, 2024)
52-week high$0.0527
52-week low$0.0461
Median price$0.0494
Average price$0.0509
Largest weekly change-29.2% (Nov 20, 2024)
Weeks tracked116
Tracking sinceJun 5, 2024

Price History

1W

-0.7%

1M

-0.7%

3M

+0.2%

6M

-2.1%

1Y

-12.4%

3Y

N/A

5Y

N/A

All

-6.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MECLIZINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of MECLIZINE 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0462 per EA (NDC 59651080701), effective Aug 19, 2026.

How has the price of MECLIZINE 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has declined 6.7%. It has been tracked across 116 weekly CMS publications since Jun 5, 2024.

What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?

Since Jun 5, 2024, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0418 (Nov 20, 2024) to a high of $0.0638 (Jul 10, 2024), with a median of $0.0494 per EA.

Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of MECLIZINE 12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MECLIZINE 12.5 MG TABLET?

MECLIZINE 12.5 MG TABLET (NDC 59651080701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.